Figs Inc is a company that specializes in designing and producing high-quality, stylish scrubs and medical apparel for healthcare professionals. With a focus on comfort, functionality, and modern aesthetics, Figs aims to revolutionize the way medical uniforms are perceived and worn. The company leverages innovative fabrics and inclusive sizing to cater to the diverse needs of its customers, ultimately enhancing the work experience for those in the medical field. In addition to scrubs, Figs also offers various accessories and lifestyle products tailored for healthcare workers, fostering a sense of community and pride among its clientele. Read More
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Healthcare apparel company Figs (NYSE:FIGS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.7% year on year to $124.9 million. Its GAAP profit of $0.01 per share was $0.01 above analysts’ consensus estimates.
FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its first quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match.
The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
A company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx.
A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are "likely to move us further away from our goals," referring to the Fed's dual mandate of price stability and maximum employment.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at apparel and accessories stocks, starting with Figs (NYSE:FIGS).
Goldman Sachs analyst Brooke Roach warns that U.S. tariff hikes will significantly impact retail, with China's tariff rate soaring to 54% and key sourcing nations like Vietnam (46%) and Cambodia (49%) facing steep increases. Apparel and footwear tariffs will average 38%, forcing brands to adjust pricing and negotiate costs.
FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the “Board”), effective April 1, 2025 (the “Effective Date”).
Figs’s stock price has taken a beating over the past six months, shedding 28.9% of its value and falling to $4.86 per share. This may have investors wondering how to approach the situation.
Expensive stocks often command premium valuations because the market thinks their business models are exceptional.
However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.
Healthcare apparel company Figs (NYSE:FIGS) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 4.8% year on year to $151.8 million. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.
FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Raymond James 46th Annual Institutional Investors Conference on Monday, March 3, 2025, at 11:00 a.m. ET.
